Medicine recalls
|
| |
| The United Kingdom: Class 2 Medicines Recall: Lipitor (Atorvastatin) 80mg film-coated tablets / Atorvastatin 80mg film-coated tablets, Almus livery |
| |
The Medicines and Healthcare products Regulatory Agency (MHRA) announces that Pfizer Ireland Pharmaceuticals is recalling the following batches of Lipitor (Atorvastatin) 80mg film-coated tablets (batch number: T43166 and T43170; expiry date: 31 Jan 2020) and Atorvastatin 80mg film-coated tablets, Almus livery (batch number: T43157; expiry date: 31 Jan 2020).
This recall is a precaution due to an out of specification result for microbiological testing during routine stability studies on a batch of the product which was not released to the market. The above batches were identified as being potentially affected by the same issue during the root cause investigation, although no out of specification microbiological results have been reported for these batches.
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/class-2-medicines-recall-lipitor-atorvastatin-80mg-film-coated-tablets-atorvastatin-80mg-film-coated-tablets-almus-livery
In Hong Kong, there are 2 pharmaceutical products registered by Pfizer Corporation Hong Kong Limited (Pfizer) containing atorvastatin 80mg, namely Lipitor Tab 80mg (HK-49653) and Xarator Tablets 80mg (HK-64251), while Atorvastatin 80mg film-coated tablets, Almus livery is not a registered pharmaceutical product. Both Lipitor and Xarator tablets are prescription only medicines. As confirmed by Pfizer, the affected batches have not been imported into Hong Kong.
Ends/Tuesday, Nov 28, 2017
Issued at HKT 15:00
|
| |
